hemolytic


Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.

he·mol·y·sis

 (hĭ-mŏl′ĭ-sĭs, hē′mə-lī′sĭs)
n.
The destruction or dissolution of red blood cells, with subsequent release of hemoglobin.

he′mo·lyt′ic (hē′mə-lĭt′ĭk) adj.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Adj.1.hemolytic - relating to or involving or causing hemolysis; "hemolytic anemia"
Translations

he·mo·lyt·ic

a. hemolítico-a, rel. a hemólisis o que la produce;
___disordertrastorno ___.

hemolytic

adj hemolítico
References in periodicals archive ?
Primary thrombocytopenic purpura and acquired hemolytic anemia; evidence for a common etiology.
M2 PHARMA-June 26, 2019-US FDA Accepts Supplemental Biologics License Application for Ultomiris (ravulizumab-cwvz) under Priority Review for the Treatment of Atypical Hemolytic Uremic Syndrome
There may be several causes of autoimmune hemolytic anemia (AIHA).
Food and Drug Administration for the treatment of autoimmune hemolytic anemia.
Additionally, the abnormal RBCs are prematurely removed from circulation, resulting in hemolytic anemia.
Recovery occurred more often in patients with vasculitis (11 percent at two years; adjusted hazard ratio, 20.4), ischemic kidney failure (12 percent; adjusted hazard ratio, 11.4), and hemolytic uremic syndrome (13 percent; adjusted hazard ratio, 15.6), compared to patients with congenital anomalies of the kidney and urinary tract.
STEC leads to hemolytic uremic syndrome (HUS) in 15% of children under the age of 10.
On account of this case presentation, I would like to draw attention to current treatment of severe autoimmune hemolytic anemia (AIHA) in the accompaniment of the literature published in recent years.
These clots can cause serious medical problems if they restrict or block blood flow, including hemolytic anemia, thrombocytopenia.
Advances in pathogenesis and therapy of hemolytic uremic syndrome caused by Shiga toxin-2.
Autoimmune hemolytic anemia (AIHA) is a disease that is characterized with the antibody production against erythrocyte antigens and degradation of the antibody coated erythrocytes by the reticuloendothelial system.
Accordingly, the clinical manifestations of G6PD may range from none to (i) erythroblastosis fetalis, chronic hemolysis, and (iii) acute hemolytic crisis [4].